The domestic pharmaceutical market rose by 26% in the first sixmonths of this year, to over 4.8bn RON (1.15bn euros), sustained bythe second quarter trend, according to a ZF estimate based on dataprovided by Cegedim Romania market research firm.
While most sectors of the economy skidded further in the first halfof the year, the pharmaceutical market is one of the few thatcontinued to grow in 2009, together with private clinics andenergy.
In the second quarter of 2010, the market advanced by 35% against2009, to 2.5bn RON (610m euros), according to Cegedim data, thebest performance in four years.
In the wake of second quarter figures, Cegedim has upwardly revisedits projection for the pharmaceutical market's advance this yearfrom 2.5% to 5.6%.
Drug sales went up by 17.6% in the first quarter in RON and by 22%in euros, and in April-June 2009 advanced by 4.7% in RON, but slidby 8.8% in euros, according to Cegedim data.
At the same time, drug sales volumes in April-June climbed by 12.6%mainly on the 14.2% advance in pharmacies, while in hospitals thevolume shrank by 11.2%.
Pentru alte știri, analize, articole și informații din business în timp real urmărește Ziarul Financiar pe WhatsApp Channels
